LORELEI: Taselisib boosts breast tumor shrinkage

(European Society for Medical Oncology) Adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer that was both estrogen receptor positive and HER2-negative (ER+/HER2-) according to results of the LORELEI trial, presented at the ESMO 2017 Congress in Madrid.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news